Available IPD datapackage for study 'A Phase III, Randomized, Multi-Center, Double-Blind, Parallel-Group, Placebo-Controlled Safety and Efficacy Study of SPD503 in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)'

Name: Available IPD datapackage for study 'A Phase III, Randomized, Multi-Center, Double-Blind, Parallel-Group, Placebo-Controlled Safety and Efficacy Study of SPD503 in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)'
Creator: Vivli
Published: 2025-06-27 07:35:58
License: 暂无描述

DataCite Commons2025-06-27 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/dataPackages/PR00008004.0

下载链接

链接失效反馈

官方服务：

资源简介：

The purpose of this study is to assess the safety and efficacy of SPD503 (Guanfacine hydrochloride) compared to placebo in the treatment of ADHD in children and adolescents aged 6-17

提供机构：

Vivli

创建时间：

2025-06-27